Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. The 3C Study Collaborative Group Lancet. 2014 Jul 26. PMID: 25078310. Abstract CommentRecommendBookmarkWatch